Xeris Biopharma
In Prem Watsa's portfolio · Fairfax Financial Holdings
Ticker XERS
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Fairfax Financial Holdings 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2025 | Sell | 0 | |
| Q4 2024 | Reduce 18% | 139,687 | 0.0% |
| Q3 2024 | No change | 170,937 | 0.0% |
| Q2 2024 | Add 13% | 170,937 | 0.0% |
| Q1 2024 | No change | 151,395 | 0.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.